Why We Desperately Need to Develop New Antifungals
While serious fungal infections are rare, there is a limited number of approved drugs to…
While serious fungal infections are rare, there is a limited number of approved drugs to…
In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya…
Sanofi’s acquisition of its partner Translate Bio is a clear sign that pharmaceutical companies are…
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
Messenger RNA vaccines have been at the forefront of the global struggle against the Covid-19…
The Covid-19 pandemic has pushed investment and research into vaccines and public health, but will…
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
The Covid-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be a powerful…
In a blow to hopes for better protection from seasonal flu, last week’s phase III…
As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for…
RNA vaccine developer CureVac will receive a grant of up to €8.3M from a global…
The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round,…